These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26867352)

  • 21. Outlining novel cellular adjuvant products for therapeutic vaccines against cancer.
    Tefit JN; Serra V
    Expert Rev Vaccines; 2011 Aug; 10(8):1207-20. PubMed ID: 21854313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development for a novel cancer vaccine].
    Tsunoda T
    Gan To Kagaku Ryoho; 2004 Dec; 31(13):2095-9. PubMed ID: 15628750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The latest in pancreatic cancer research: Lustgarten Foundation awardees present their findings.
    Wilentz RE
    Int J Pancreatol; 2001; 29(2):123-5. PubMed ID: 11876250
    [No Abstract]   [Full Text] [Related]  

  • 24. The promise of cancer vaccines.
    Gilboa E
    Nat Rev Cancer; 2004 May; 4(5):401-11. PubMed ID: 15122211
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in Therapeutic Cancer Vaccines.
    Wong KK; Li WA; Mooney DJ; Dranoff G
    Adv Immunol; 2016; 130():191-249. PubMed ID: 26923002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DC-based cancer vaccines.
    Gilboa E
    J Clin Invest; 2007 May; 117(5):1195-203. PubMed ID: 17476349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency assays for therapeutic live whole cell cancer vaccines.
    Petricciani J; Egan W; Vicari G; Furesz J; Schild G
    Biologicals; 2007 Apr; 35(2):107-13. PubMed ID: 16882459
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MUC1 as a target antigen for cancer immunotherapy.
    Acres B; Limacher JM
    Expert Rev Vaccines; 2005 Aug; 4(4):493-502. PubMed ID: 16117706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of clinical trials for therapeutic cancer vaccines development.
    Mackiewicz J; Mackiewicz A
    Eur J Pharmacol; 2009 Dec; 625(1-3):84-9. PubMed ID: 19835869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The complete preventive effect of homologous tumor vaccines--based on a 5-year experimental study in mice.
    Tong X; Wang L; Liu Y; Qi Y; Qin Y; Xu Y; Tong T
    Biomed Pharmacother; 2010 Nov; 64(9):605-8. PubMed ID: 20961730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer vaccines: what do we need to measure in clinical trials?
    Kudrin A
    Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized Oncology Meets Immunology: The Path toward Precision Immunotherapy.
    Mandal R; Chan TA
    Cancer Discov; 2016 Jul; 6(7):703-13. PubMed ID: 27107038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patented cancer vaccines: the promising leads.
    Aurisicchio L; Ciliberto G
    Expert Opin Ther Pat; 2010 May; 20(5):647-60. PubMed ID: 20345331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer vaccines on the horizon.
    Jones D
    Nat Rev Drug Discov; 2007 May; 6(5):333-4. PubMed ID: 17539052
    [No Abstract]   [Full Text] [Related]  

  • 35. Antigen-specific vaccines for cancer treatment.
    Tagliamonte M; Petrizzo A; Tornesello ML; Buonaguro FM; Buonaguro L
    Hum Vaccin Immunother; 2014; 10(11):3332-46. PubMed ID: 25483639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor vaccines: conception, development and evaluation in humans].
    Moingeon P
    Ann Pharm Fr; 2002 Jul; 60(4):253-9. PubMed ID: 12378152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapeutic vaccination for tumors and neurodegenerative diseases].
    Scheer V; Goldammer M; Flindt S; van Zandbergen G; Hinz T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 Nov; 63(11):1373-1379. PubMed ID: 33034692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized clinical studies of anti-tumor vaccination: state of the art in 2008.
    Fournier P; Schirrmacher V
    Expert Rev Vaccines; 2009 Jan; 8(1):51-66. PubMed ID: 19093773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.